发明名称 |
ARMET AS A MARKER FOR CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) |
摘要 |
An in vitro method aiding in the assessment of chronic obstructive pulmonary disease (COPD). The disclosure further relates to a method for assessing COPD from a sample, derived from an individual, by measuring the protein ARMET in said sample in vitro. |
申请公布号 |
US2015056642(A1) |
申请公布日期 |
2015.02.26 |
申请号 |
US201414533362 |
申请日期 |
2014.11.05 |
申请人 |
Roche Diagnostics Operations, Inc. |
发明人 |
Karl Johann;Riedlinger Julia;Roessler Markus |
分类号 |
G01N33/68 |
主分类号 |
G01N33/68 |
代理机构 |
|
代理人 |
|
主权项 |
1. An in vitro method for diagnosing chronic obstructive pulmonary disease (COPD) in a patient, comprising:
determining a concentration of protein ARMET in a serum, plasma, or whole blood sample obtained from the patient; comparing the concentration of protein ARMET in the sample determined in said step of determining with a protein ARMET reference concentration; providing a diagnosis of COPD in the patient if the concentration of protein ARMET in the sample determined in said step of determining is greater than the protein ARMET reference concentration. |
地址 |
Indianapolis IN US |